vs
Side-by-side financial comparison of Leslie's, Inc. (LESL) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
Leslie's, Inc. is the larger business by last-quarter revenue ($147.1M vs $75.5M, roughly 1.9× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -16.0%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-85.5M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -11.7%).
Leslie's, Inc., operating as Leslie's Swimming Pool Supplies, is the largest retailer of swimming pool supplies and related products. The company is headquartered in Phoenix, Arizona, and has a particularly strong retail presence in Arizona, California, Florida, Georgia and Texas.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
LESL vs PBYI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $147.1M | $75.5M |
| Net Profit | $-83.0M | — |
| Gross Margin | 18.4% | 69.3% |
| Operating Margin | -46.7% | 22.7% |
| Net Margin | -56.4% | — |
| Revenue YoY | -16.0% | 27.7% |
| Net Profit YoY | -86.2% | — |
| EPS (diluted) | $-8.92 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $147.1M | — | ||
| Q4 25 | $389.2M | $75.5M | ||
| Q3 25 | — | $54.5M | ||
| Q2 25 | $500.3M | $52.4M | ||
| Q1 25 | $177.1M | $46.0M | ||
| Q4 24 | $175.2M | $59.1M | ||
| Q3 24 | $397.9M | $80.5M | ||
| Q2 24 | $569.6M | $47.1M |
| Q1 26 | $-83.0M | — | ||
| Q4 25 | $-162.8M | — | ||
| Q3 25 | — | $8.8M | ||
| Q2 25 | $21.7M | $5.9M | ||
| Q1 25 | $-51.3M | $3.0M | ||
| Q4 24 | $-44.6M | — | ||
| Q3 24 | $-9.9M | $20.3M | ||
| Q2 24 | $60.6M | $-4.5M |
| Q1 26 | 18.4% | — | ||
| Q4 25 | 38.6% | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | 39.6% | 76.5% | ||
| Q1 25 | 24.8% | 77.1% | ||
| Q4 24 | 27.2% | 76.4% | ||
| Q3 24 | 36.0% | 63.9% | ||
| Q2 24 | 40.2% | 77.4% |
| Q1 26 | -46.7% | — | ||
| Q4 25 | -38.6% | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | 13.7% | 12.7% | ||
| Q1 25 | -27.3% | 8.7% | ||
| Q4 24 | -22.7% | 22.6% | ||
| Q3 24 | 6.6% | 27.4% | ||
| Q2 24 | 17.2% | -4.6% |
| Q1 26 | -56.4% | — | ||
| Q4 25 | -41.8% | — | ||
| Q3 25 | — | 16.2% | ||
| Q2 25 | 4.3% | 11.2% | ||
| Q1 25 | -29.0% | 6.5% | ||
| Q4 24 | -25.4% | — | ||
| Q3 24 | -2.5% | 25.2% | ||
| Q2 24 | 10.6% | -9.6% |
| Q1 26 | $-8.92 | — | ||
| Q4 25 | $-20.59 | $0.26 | ||
| Q3 25 | — | $0.17 | ||
| Q2 25 | $0.12 | $0.12 | ||
| Q1 25 | $-0.28 | $0.06 | ||
| Q4 24 | $-4.82 | $0.40 | ||
| Q3 24 | $-2.46 | $0.41 | ||
| Q2 24 | $0.33 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $97.5M |
| Total DebtLower is stronger | $781.6M | $22.7M |
| Stockholders' EquityBook value | $-489.9M | $130.3M |
| Total Assets | $649.4M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $3.6M | — | ||
| Q4 25 | $64.3M | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | $42.7M | $96.0M | ||
| Q1 25 | $17.3M | $93.2M | ||
| Q4 24 | $11.6M | $101.0M | ||
| Q3 24 | $108.5M | $96.7M | ||
| Q2 24 | $74.4M | $96.8M |
| Q1 26 | $781.6M | — | ||
| Q4 25 | $756.6M | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | $776.6M | $45.3M | ||
| Q1 25 | $858.1M | $56.7M | ||
| Q4 24 | $796.6M | $68.0M | ||
| Q3 24 | $783.7M | $79.3M | ||
| Q2 24 | $783.7M | $90.7M |
| Q1 26 | $-489.9M | — | ||
| Q4 25 | $-408.0M | $130.3M | ||
| Q3 25 | — | $115.3M | ||
| Q2 25 | $-246.2M | $104.7M | ||
| Q1 25 | $-269.5M | $97.1M | ||
| Q4 24 | $-220.0M | $92.1M | ||
| Q3 24 | $-177.1M | $71.1M | ||
| Q2 24 | $-168.2M | $48.5M |
| Q1 26 | $649.4M | — | ||
| Q4 25 | $741.5M | $216.3M | ||
| Q3 25 | — | $202.9M | ||
| Q2 25 | $989.5M | $194.9M | ||
| Q1 25 | $1.0B | $196.2M | ||
| Q4 24 | $967.0M | $213.3M | ||
| Q3 24 | $1.1B | $220.7M | ||
| Q2 24 | $1.1B | $205.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-81.1M | $14.4M |
| Free Cash FlowOCF − Capex | $-85.5M | $14.4M |
| FCF MarginFCF / Revenue | -58.1% | 19.1% |
| Capex IntensityCapex / Revenue | 2.9% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $7.6M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-81.1M | — | ||
| Q4 25 | $48.2M | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | $114.9M | $14.1M | ||
| Q1 25 | $-49.2M | $3.6M | ||
| Q4 24 | $-105.1M | $15.6M | ||
| Q3 24 | $47.1M | $11.0M | ||
| Q2 24 | $175.5M | $1.0M |
| Q1 26 | $-85.5M | — | ||
| Q4 25 | $41.8M | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | $107.1M | $14.1M | ||
| Q1 25 | $-55.8M | $3.6M | ||
| Q4 24 | $-109.8M | $15.6M | ||
| Q3 24 | $34.1M | $11.0M | ||
| Q2 24 | $165.2M | $1.0M |
| Q1 26 | -58.1% | — | ||
| Q4 25 | 10.7% | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | 21.4% | 26.8% | ||
| Q1 25 | -31.5% | 7.7% | ||
| Q4 24 | -62.6% | 26.4% | ||
| Q3 24 | 8.6% | 13.7% | ||
| Q2 24 | 29.0% | 2.1% |
| Q1 26 | 2.9% | — | ||
| Q4 25 | 1.7% | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | 1.6% | 0.0% | ||
| Q1 25 | 3.7% | 0.1% | ||
| Q4 24 | 2.7% | 0.0% | ||
| Q3 24 | 3.2% | 0.0% | ||
| Q2 24 | 1.8% | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | 5.29× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | 2.89× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
